Shifting from targeted therapies to personalised treatment in chordoma

Lancet Oncol. 2020 Dec;21(12):e547. doi: 10.1016/S1470-2045(20)30684-7.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Chordoma*
  • Humans
  • Molecular Targeted Therapy
  • Precision Medicine
  • Pyridines / therapeutic use

Substances

  • Pyridines
  • apatinib